openPR Logo
Press release

North America Synthetic Opioids Market Research Study: Forecast 2016 -2024, Full Report TOC

07-24-2017 01:42 PM CET | Health & Medicine

Press release from: Persistence Market Research Pvt. Ltd

North America Synthetic Opioids Market Research Study:

Demand for synthetic opioids continues to witness a decline in North America. According to a new research from Persistence Market Research, the US$ 75 billion synthetic opioids market will grow at a sluggish 2.4% during the period 2016-2024.

Rising concerns about the addictive nature of opioids, combined with drug abuse has led to declining sales. According to the Centers for Disease Control and Prevention (CDC) around 33,000 Americans died from opioid overdose in 2015. The agency also reported that almost half of non-cancer patients who have been prescribed opioids for a month are still dependent on the pills a year later. Further, side effects of synthetic opioids, such as reduce libido, urinary difficulties, appetite loss, and spells of dizziness are also influencing sales negatively.

Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/north-america-synthetic-opioids-market.asp

According to Persistence Market Research, introduction of non-abuse opioid drugs and drug exclusivity for branded options are the opportunities for pharmaceutical companies.

Persistence Market Research’s study on the North America synthetic opioids market revealed that only 18% of opioids are obtained from licensed physicians. The report also found that increasing government regulations and DEA cuts can reduce unauthorized access.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/15898

Table Of Content

1. North America Synthetic Opioids Market Executive Summary

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. North America Synthetic Opioids Market Analysis Scenario
3.1. Average Selling Pricing Analysis
3.1.1. Pricing Assumptions
3.2. Market Size (US$ Bn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
3.2.2. Absolute $ Opportunity

4. North America Synthetic Opioids Market Dynamics
4.1. Macro-Economic Factors
4.2. Drivers
4.2.1. Demand Side
4.2.2. Supply Side
4.3. Restraints
4.4. Opportunities
4.5. Market Trends
4.6. Per capita consumption
4.7. Opioids regulatory agencies
4.8. State wise Analysis
4.9. Healthcare Burden
4.10. Sources of opioid painkillers

5. North America Synthetic Opioids Market Value Analysis and Forecast, by Product type
5.1. Introduction
5.1.1. Basis Point Share (BPS) Analysis by Product type
5.1.2. Y o Y Growth Projections by Product type
5.2. North America Synthetic Opioids Market Size (Value and Volume) and Forecast, by Product type
5.2.1. Synthetic Opioids
5.2.1.1 Methadone
5.2.1.2 Fentanyl
5.2.1.3 Meperidine
5.2.2. Semisynthetic Opioids
5.2.2.1 Hydrocodone
5.2.2.2 Oxymorphone
5.2.2.3 Oxycodone
5.2.2.4 Hydromorphone
5.2.2.5 Buprenorphine
5.3. North America Synthetic Opioids Market Attractiveness Analysis by Product type
5.4. Prominent Trends

6. North America Synthetic Opioids Market Analysis and Forecast, by Application
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Application
6.1.2. Y o Y Growth Projections by Application
6.2. North America Synthetic Opioids Market Size and Forecast, by Application
6.2.1. Pain Management
6.2.2. De-addiction
6.3. North America Synthetic Opioids Market Attractiveness Analysis, by Application
6.4. Prominent trends

7. North America Synthetic Opioids Market Analysis and Forecast, by Distribution Channel
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Distribution Channel
7.1.2. Y o Y Growth Projections by Distribution Channel
7.2. North America Synthetic Opioids Market Size and Forecast, by Distribution Channel
7.2.1. Retail Outlets
7.2.2. Hospitals
7.3. North America Synthetic Opioids Market Attractiveness Analysis, by Distribution Channel

8. North America Synthetic Opioids Market Analysis and Forecast, by Country
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y o Y Growth Projections by Country
8.2. North America Synthetic Opioids Market Size and Forecast, by Country
8.2.1. U.S
8.2.2. Canada
8.3. North America Synthetic Opioids Market Attractiveness Analysis, by Country

9. U.S. Synthetic Opioids Market Analysis and Forecast
9.1. Introduction
9.2. Synthetic Opioids Market Size Value (US$ Bn) Forecast by Product type
9.2.1. Synthetic Opioids
9.2.1.1 Methadone
9.2.1.2 Fentanyl
9.2.1.3 Meperidine
9.2.2. Semisynthetic Opioids
9.2.2.1 Hydrocodone
9.2.2.2 Oxymorphone
9.2.2.3 Oxycodone
9.2.2.4 Hydromorphone
9.2.2.5 Buprenorphine
9.3. Synthetic Opioids Market Size (US$ Bn) Forecast by Application
9.3.1. Pain Management
9.3.2. De-addiction
9.4. Synthetic Opioids Market Size (US$ Bn) Forecast by Distribution Channels
9.4.1. Retail Outlets
9.4.2. Hospitals
9.5. Synthetic Opioids Market Attractiveness Analysis
9.5.1. by Product type
9.5.2. by Application
9.5.3. by Distribution Channels

10. Canada Synthetic Opioids Market Analysis and Forecast
10.1. Introduction
10.2. Synthetic Opioids Market Size Value (US$ Bn) Forecast by Product type
10.2.1. Synthetic Opioids
10.2.1.1 Methadone
10.2.1.2 Fentanyl
10.2.1.3 Meperidine
10.2.2. Semisynthetic Opioids
10.2.2.1 Hydrocodone
10.2.2.2 Oxymorphone
10.2.2.3 Oxycodone
10.2.2.4 Hydromorphone
10.2.2.5 Buprenorphine
10.3. Synthetic Opioids Market Size (US$ Bn) Forecast by Application
10.3.1. Pain Management
10.3.2. De-addiction
10.4. Synthetic Opioids Market Size (US$ Bn) Forecast by Distribution Channels
10.4.1. Retail Outlets
10.4.2. Hospitals
10.5. Synthetic Opioids Market Attractiveness Analysis
10.5.1. by Product type
10.5.2. by Application
10.5.3. by Distribution Channels

11. Competitive Landscape
11.1. Company Dashboard
11.2. Company Profiles
11.2.1. Revenue
11.2.2. Company Highlights
11.2.3. Market Players
11.2.3.1. Purdue Pharma LP
11.2.3.2. Pfizer Inc.
11.2.3.3. Janssen Pharmaceuticals, Inc.
11.2.3.4. Teva Pharmaceuticals
11.2.3.5. Endo International plc
11.2.3.6. West-Ward Pharmaceuticals (Hikma’s US subsidiary)
11.2.3.7. Mallinckrodt Pharmaceuticals plc
11.2.3.8. Mylan N.V.
11.2.3.9. Impax Laboratories, Inc.
11.2.3.10. Indivior Plc.

12. Assumptions and Acronyms Used

13. Research Methodology

Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/15898

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America Synthetic Opioids Market Research Study: Forecast 2016 -2024, Full Report TOC here

News-ID: 638420 • Views:

More Releases from Persistence Market Research Pvt. Ltd

Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Market to Hit Surpass US$ 679.6 Million by 2032
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032. The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthetic Lasers Market
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism. Stay Ahead with Market Intelligence Get Free
Predictive Insights for Precision Medicine: The Global Biosimulation Market is Set to Hit USD 10 billion by 2030
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.  Market Overview The biosimulation market has experienced rapid growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheelchairs to Boost Growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961 The global wheelchair and components market has witnessed significant growth in

All 5 Releases


More Releases for Opioids

The Opioids Market to grow with biosensors
The Opioids Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare system. Demand for synthetic
Wearable Electronics to Revolutionize the Opioids Market
Opioids are a type of narcotic pain medication that is used to treat moderate to severe pains, such as traumatic pain, cough suppression, diarrhoea suppression, surgical pain, injuries, cancer pain, and pain arising due to chronic diseases. However, opioids have both, benefits as well as potentially severe risks of addiction. Opioids prescribed as pain relievers are usually safer if consumed for a short period of time. Long-term use can lead
Global Opioids Market Outlook To 2026
Global Opioids Market Outlook To 2026: In-Depth Market Overview, Key Product Categories (Immediate-Release/Short-Acting, Extended-Release/Long-Acting, Codeine, Oxycodone, Hydrocodone, Fentanyl, Morphine, Hydroxymorphone, Oxymorphone, Propoxyphene, Methadone, Tapentadol, Buprenorphine), Application (Pain Relief, Cancer Pain, Post-Operative Pain Management, Low Back Pain, Orthopedic, Anesthesia, Neuropathic Pain, Fibromyalgia, Cough Suppression, Diarrhoea Suppression, De-Addiction), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion The Opioids Market was valued at $xx.7Billion in 2018 and is
Global Opioids Market Research Report
This report studies the global Opioids market status and forecast, categorizes the global Opioids market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Purdue Pharma L.P. West-Ward Pharmaceuticals Corporation Allergan Pfizer, Inc. Janssen Pharmaceuticals, Inc. Egalet Corporation Sun Pharmaceutical Industries Limited. Geographically,
Opioids Market –Used to Moderate To Severe Pain-Opioids Can Be Addictive Owing …
Market Analysis with Latest Growth Factors: Factors such as intense focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF), rising palliative care facilities, and reformed regulations for opioids prescription are anticipated to fuel the opioids market growth in North America and Europe. Intense focus on palliative care and increasing healthcare expenditure are major factors that propel the opioids market growth. Also, rise in the incidence of orthopedic disorders & chronic pain
Opioids Market Research Report Forecast to 2025
Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and also to treat severe constant pain in patients suffering from terminal illnesses. These are generally administered via subcutaneous, oral and intramuscular routes; other routes of administration include nasal insufflations, patient controlled analgesia, transdermal and oral mucosa routes via lozenges. Opioids can be classified into three